Association between the Khorana score and pulmonary embolism risk in patients with advanced stage lung cancer

• DOI: 10.1111/crj.13092
• Publication Date: 2019-10-04T18:34:30Z
• Authors: Austėja Dapkevičiūtė; Aurelija Daškevič...; Rolandas Zablockis; Aušrinė Kuzaitė; Gintarė Jonušienė; Saulius Diktanas; Edvardas Danila
• Keywords: Male; Inpatients; Lung Neoplasms; Incidence; Anticoagulants; Middle Aged; Risk Assessment; 3. Good health; 03 medical and health sciences; 0302 clinical medicine; Drug Therapy; Humans; Female; Pulmonary Embolism; Aged; Neoplasm Staging; Retrospective Studies

The Khorana score may help physicians to identify patients at high risk of Pulmonary embolism (PE) and decide who is eligible for thromboprophylaxis, however, its role in lung cancer remains unclear.The aim this study was evaluate association between the PE development among advanced stage inpatients treated with chemotherapy.A retrospective cohort included 2008-2017 year data 217 IIIB IV clinical stages receiving chemotherapy. evaluated were divided two groups: a group 1 point 2 or more points score.The population 46 (21.2%) female 171 (78.8%) male whose median age 62. During observation period 308.5 days 26 (11.9%) developed PE. Study 137 80 score. frequency 17 (12.4%) 9 (11.3%) relative 0.895 (95% CI = 0.379-2.114), P 0.800.The not associated